Synthego's Ch. 11 Fueled By High Costs, Patent Fight
By Yun Park · June 27, 2025, 6:17 PM EDT
Rising costs, heavy investment that outpaced growth and patent litigation led California-based biotechnology company Synthego Corp. to file for Chapter 11 with up to $500 million in debt and a plan...
To view the full article, register now.